ATTR Epidemiology, Genetics, and Prognostic Factors
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed disease and an underestimated cause of both heart failure and conduction abnormalities. It is characterized by pathologic accumulation of extracellular protein arising from unstable transthyretin (TTR) tetramers, which dissociate in...
Saved in:
| Main Authors: | Chukwuemeka A. Obi, William C. Mostertz, Jan M. Griffin, Daniel P. Judge |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Houston Methodist DeBakey Heart & Vascular Center
2022-03-01
|
| Series: | Methodist DeBakey Cardiovascular Journal |
| Subjects: | |
| Online Access: | https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1066 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Delays in diagnosis and treatment of ATTR cardiac amyloidosis: A real‐world data analysis
by: Julia Vogel, et al.
Published: (2025-08-01) -
Dynamic changes of intracellular signals in ATTR Tyr114Cys amyloidosis
by: Kenta Ouchi, et al.
Published: (2025-06-01) -
The journey to diagnosis of wild-type transthyretin-mediated (ATTRwt) amyloidosis: a path with multisystem involvement
by: Chafic Karam, et al.
Published: (2024-11-01) -
Phenotypic heterogeneity and diagnostic features of transthyretin amyloidosis with polyneuropathy
by: S. S. Nikitin, et al.
Published: (2021-12-01) -
Unravelling the myriad physiologic roles of transthyretin: critical considerations for treating transthyretin amyloidosis
by: Morie A. Gertz, et al.
Published: (2025-12-01)